Greg Stock, MD
A leading authority on the broad impacts of genomic and other advanced technologies in the life sciences visionary game changer, Gary Stock, MD, addresses such questions as: Who are we? Will we extend the human lifespan? Where are the new therapeutics? Are we the next frontier? Gregory Stock has created a new paradigm for personal inquiries into values and beliefs, and influenced the major shift occurring in our vision of what it is to be human in the face of the major developments being ushered in by the silicon and biotech revolutions. He has written a range of thoughtful works on the impact and significance of recent advances in technology and the life sciences and has had a series of bestsellers on values and ethics.
Fee: Call For Quote
Dr. Gregory Stock, a biotech entrepreneur, bioethicist, best-selling author and public communicator is a leading authority on the broad impacts of genomic and other advanced technologies in the life sciences. He founded the influential Program on Medicine, Technology and Society at UCLA's School of Medicine in 1997 and served as its director for ten years while leading a broad effort to explore critical technologies poised to impact humanity's future and reshape medical science. Through a series of high-profile symposia, lectures, and media appearances, Stock has catalyzed broad public debate about the social and public policy implications of today's revolution in molecular genetics and bioinformatics, and about how most effectively to translate progress in basic science into improved therapeutics and healthcare.
Dr. Stock is a strong advocate for aggressive biomedical funding and research, and for cautious governmental oversight. In 2004, Stock co-founded Signum Biosciences, a Princeton University spinoff created to develop a new class of anti-inflammatories and therapeutics for neurodegeneration. He served as the CEO of Signum for 6 years directing efforts there to develop promising pharma candidates for Alzheimer's and Parkinson's.
Dr. Stock has been an invited speaker to many academic, government and business conferences. He sits on the editorial board of the American Journal of Bioethics, The Journal of Evolution and Technology, and Rejuvenation Research and was invited to submit an Advisory Memo to the President on the challenges ahead. Stock has been profiled in the Wall Street Journal, New York Times, MIT Tech Review and Lancet. He makes regular appearances on television and radio, including CNN, PBS, NPR, Bloomberg and the BBC and frequently debates biotech policy with Francis Fukuyama, Jeremy Rifkin, Leon Kass, Daniel Callahan, Bill McKibben, George Annas and other prominent voices who would rein in biomedical research.
Dr. Stock's book, Redesigning Humans: Our Inevitable Genetic Future with Houghton Mifflin won the prestigious Kistler Book Prize for Science books and was nominated for a Wired Rave Award. Among his other books are Engineering The Human Germline: An Exploration of the Science and Ethics of Altering the Genes We Pass to Our Children with Oxford University Press, Metaman: The Merging of Humans and Machine into a Global Superorganism with Simon & Schuster, and the best selling, Book of Questions with Workman Press, which has sold over 2 million copies, been translated into 18 languages and is now in its 61st printing. Sequels to that book include The Book of Questions: Business, Politics, and Ethics, The Book of Questions: Love and Sex, and The Kids' Book of Questions as well as a new book that will explore how future technology will challenge our values and alter our lives.
Gregory Stock serves on the California Advisory Committee on Stem Cells and Reproductive Cloning and is the Associate Director of the Center for Life Science Policy Studies, a policy think tank at the University of California at Berkeley. He serves on the boards of Signum Biosciences and Napo Pharmaceuticals, a private pharmaceutical company with an important drug approaching approval for diarrhea associated with HIV retroviral therapy and Cholera. He has a Doctorate in Biophysics from Johns Hopkins University and an MBA from Harvard University.
Selected Honors & Awards
• Alzheimer's Drug Discovery Foundation Special Recognition (Sotheby's).
• Fellow, World Academy of Art and Science (WAAS)
• Fellow, World Technology Council.
• Kistler Book Award For Best Science Book of 2002, Redesigning Humans
• Wired Magazine Nominee for Rave Award for Best Book of 2002
• Invited Advisory Memo to President Clinton: Challenges of the Next Century
• Book of Questions #1 NY Times Best Seller for 8 wks, top 10 for 32 weeks
• Kids' Book of Questions in top-10 best-selling Children's Books for 12 weeks
• Presidential Grants, Alfred P Sloan Foundation and Greenwall Foundation
• Innovation Grant, Robert Graham Foundation
• Candidate, US House of Representatives, 36th District, Los Angeles
• Freund-Porter Entrepreneurship Award, Harvard Business School
• Jasse Award for Distinction in Leadership, Harvard Business School
• Baker Scholar, Harvard Business School
• Phi Beta Kappa, Johns Hopkins University